Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21146661rdf:typepubmed:Citationlld:pubmed
pubmed-article:21146661lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:21146661lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:21146661lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:21146661lifeskim:mentionsumls-concept:C0247025lld:lifeskim
pubmed-article:21146661lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:21146661lifeskim:mentionsumls-concept:C1704686lld:lifeskim
pubmed-article:21146661lifeskim:mentionsumls-concept:C0205174lld:lifeskim
pubmed-article:21146661lifeskim:mentionsumls-concept:C0035124lld:lifeskim
pubmed-article:21146661lifeskim:mentionsumls-concept:C0439227lld:lifeskim
pubmed-article:21146661pubmed:issue6lld:pubmed
pubmed-article:21146661pubmed:dateCreated2010-12-14lld:pubmed
pubmed-article:21146661pubmed:abstractTextIt is known that the efficacy of thrombolytic therapy in ST-segment elevation myocardial infarction (STEMI) is highly time dependent with the best efficacy when given within the so-called golden hour. This analysis from the On-TIME 2 trial evaluated the efficacy of triple antiplatelet therapy on initial patency and ST-segment resolution (STR) in relation to time from symptom onset to first medical contact.lld:pubmed
pubmed-article:21146661pubmed:languageenglld:pubmed
pubmed-article:21146661pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21146661pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21146661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21146661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21146661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21146661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21146661pubmed:statusMEDLINElld:pubmed
pubmed-article:21146661pubmed:monthDeclld:pubmed
pubmed-article:21146661pubmed:issn1097-6744lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:BoersmaEricElld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:StellaPieter...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:ten...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:DillThorstenTlld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:van 't...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:ZijlstraFelix...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:GosselinkA...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:HammChristian...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:MosterdArendAlld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:KoopmansPetra...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:HeestermansTo...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:21146661pubmed:authorpubmed-author:KochmanWaclav...lld:pubmed
pubmed-article:21146661pubmed:copyrightInfoCopyright © 2010 Mosby, Inc. All rights reserved.lld:pubmed
pubmed-article:21146661pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21146661pubmed:volume160lld:pubmed
pubmed-article:21146661pubmed:ownerNLMlld:pubmed
pubmed-article:21146661pubmed:authorsCompleteYlld:pubmed
pubmed-article:21146661pubmed:pagination1079-84lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:meshHeadingpubmed-meshheading:21146661...lld:pubmed
pubmed-article:21146661pubmed:year2010lld:pubmed
pubmed-article:21146661pubmed:articleTitleThe golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.lld:pubmed
pubmed-article:21146661pubmed:affiliationDepartment of Cardiology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands.lld:pubmed
pubmed-article:21146661pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21146661pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:21146661pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:21146661pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed